Skip to main content
Caplight Logo









Nanovision Technology

Nanovision Technology

Private
NanjingHealthcare & Life Scienceshttps://nanovision.cn

Last Round

Series C

Extension

Nov 30, 2024

Est. Valuation

$4.48B

Total Funding Raised

$190.93M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nanovision Technology is a medical device company that specializes in the research, development, production, and service of high-speed, high-precision radiation imaging solutions, including phased array CT systems, X-ray detectors, and medical imaging software.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

phased array CTcomputed tomographymedical imagingindustrial inspectionCT scannerX-ray detectorX-ray sourceradiography softwaremedical devicenon-destructive testingNDTimage reconstructionCTbionic imagingmedical hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanovision Technology Comparables

Compare Nanovision Technology with similar companies based on industry and business-model similarity.

Nanovision Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai United Imaging Healthcare
77%
MinFound Medical Systems Co., Ltd.
77%
NuRay Technology Co., Ltd.
76%

Nanovision Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionNov 30, 2024
Private PlacementJul 12, 2022
StrategicMar 23, 2022
Series CNov 11, 2021
IPOJun 23, 2021
Series C Extension
Feb 1, 2020

Nanovision Technology Investors

Notable investors and investment history

Nanovision Technology investors
InvestorRounds
Guotai Junan Securities (Hong Kong) LimitedPrivate Placement
China Galaxy Securities Co., Ltd.Private Placement
SDIC Unity CapitalSeries B, Series C
Hillhouse InvestmentSeries B
YuanBio Venture CapitalSeries B, Series C, Series A
Northern Light Venture CapitalSeries C
Huimei CapitalSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 11, 2026

    Weitao Li joins as Director of Corporate Communications.

  • Jul 12, 2022

    $29M raised from Caitong Fund Management, GF Fund, and others.

Nanovision Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanovision Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanovision Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersNanjing
Employee Range22
Year Founded2014
Last FundingNov 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?